Patient Leaflet Updated 24-May-2023 | AstraZeneca UK Limited
Symbicort, 100 micrograms/3 micrograms/actuation pressurised inhalation, suspension
Symbicort® 100 micrograms/3 micrograms/actuation pressurised inhalation, suspension
Budesonide/Formoterol fumarate dihydrate
1. What Symbicort is and what it is used for
2. What you need to know before you use Symbicort
3. How to use Symbicort
4. Possible side effects
5. How to store Symbicort
6. Contents of the pack and other information
Symbicort is an inhaler that is used to treat asthma in adults and adolescents aged 12-17 years. It contains two different medicines: budesonide and formoterol fumarate dihydrate.
Symbicort is used to treat asthma, and can be prescribed alone or with a separate reliever inhaler:
Some people are prescribed two asthma inhalers: Symbicort inhaler and a separate ‘reliever inhaler’
Some people are prescribed Symbicort as their only asthma inhaler
Talk to your doctor or pharmacist before using Symbicort if:
Talk to your doctor while using Symbicort if you have blurred vision or other visual disturbances.
Do not use this medicine in children under 12 years.
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
In particular, tell your doctor or pharmacist if you are using any of the following medicines:
If any of the above applies to you, or if you are not sure, talk to your doctor or pharmacist before using Symbicort.
Also tell your doctor or pharmacist if you are going to have a general anaesthetic for an operation or for dental work.
Symbicort has no or very little effect on your ability to drive or to use tools or machines.
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Symbicort can be prescribed for asthma alone or with a separate reliever inhaler. You need to take two puffs (actuations) of Symbicort to get a full dose. The amount of Symbicort to use and when to use it depends on how it has been prescribed for you.
a) If you have been prescribed Symbicort and a separate reliever inhaler, read the section called ‘a) Using Symbicort and a separate reliever inhaler’.
b) If you have been prescribed Symbicort as your only inhaler, read the section called ‘b) Using Symbicort as your only asthma inhaler’.
Use Symbicort every day. This helps to prevent signs of asthma.
Adults (18 years and above)
Adolescents (12 to 17 years)
Your doctor (or asthma nurse) will help you to manage your asthma. They will adjust the dose of this medicine to the lowest dose that controls your asthma. However, do not adjust or stop the dose without talking to your doctor (or asthma nurse) first.
Use your separate ‘reliever inhaler’ to treat asthma symptoms when they happen.
Only use Symbicort in this way if your doctor has told you to and if you are aged 12 or above.
Use your Symbicort every day. This helps to prevent signs of asthma. You can take either:
Your doctor may increase this to 4 puffs twice a day.
Also use Symbicort as a ‘reliever inhaler’ to treat asthma symptoms when they happen and to prevent asthma symptoms from happening (for example, when exercising or on exposure to allergens).
Always keep your Symbicort inhaler with you, so you can use it when you need it.
A total daily dose of more than 16 puffs is not normally needed. However, your doctor may allow you to take up to 24 puffs a day for a limited period.
If you regularly need to use 16 or more puffs a day, make an appointment to see your doctor or nurse. They may need to change your treatment.
Do not use more than 24 puffs in 24 hours.
If you are doing exercise and you get signs of asthma, use Symbicort as described here. It is important that you discuss with your doctor the use of Symbicort to prevent asthma symptoms from happening; how often you exercise or how often you are exposed to allergens could impact the treatment that it is prescribed to you.
If you have been taking steroid tablets for your asthma, your doctor may reduce the number of tablets that you take, once you start to use Symbicort. If you have been taking oral steroid tablets for a long time, your doctor may want you to have blood tests from time to time. When reducing oral steroid tablets, you may feel generally unwell even though your chest symptoms may be improving. Signs may include:
Talk to your doctor immediately if you have signs such as:
If you get any of the signs above, talk to your doctor immediately- you may need to take other medication. Talk to your doctor if you are concerned as to whether you should continue to use Symbicort.
Other forms of this medicine are suitable for children; ask your doctor or pharmacist.
If you feel you are getting breathless or wheezy while using Symbicort, you should continue to use Symbicort but go to see your doctor as soon as possible, as you may need additional treatment.
Talk to your doctor immediately if:
You need to prepare your inhaler for use in the following situations:
To prepare your inhaler for use, follow the instructions below:
1. Shake the inhaler well for at least 5 seconds to mix the contents of the aerosol canister.
2. Remove the mouthpiece cover by pressing lightly on the bumps on the side. The strap on the mouthpiece cover will stay attached to the inhaler.
3. Hold the inhaler upright. Then press the counter (on the top of the inhaler) to release a puff into the air. You can use one or both hands, as shown in the pictures.
4. Release your finger(s) from the counter.
5. Wait for 10 seconds, shake well and then repeat steps 3 and 4.
6. Your inhaler is now ready for use.
Each time you need to take an inhalation, follow the instructions below:
1. Shake the inhaler well for at least 5 seconds to mix the contents of the aerosol canister.
2. Remove the mouthpiece cover by pressing lightly on the bumps on the side. Check that the mouthpiece is not blocked.
3. Hold your inhaler upright (using one or both hands). Breathe out gently.
4. Place the mouthpiece gently between your teeth. Close your lips.
5. Start to breathe in slowly and deeply through your mouth. Press the counter (on the top of the inhaler) firmly to release a puff. Keep breathing in for a short while after pressing the counter. Breathing in at the same time as pressing the counter ensures that the medicine reaches your lungs.
6. Hold your breath for 10 seconds, or for as long as it is comfortable.
7. Before you breathe out, release your finger from the counter and remove the inhaler from your mouth. Keep the inhaler upright.
8. Then breathe out slowly. To take another inhalation, shake the inhaler well for at least 5 seconds and repeat steps 3 to 7.
9. Replace the mouthpiece cover.
10. Rinse your mouth with water after your daily morning and evening doses and spit it out.
Your doctor, nurse or pharmacist may suggest that you use a spacer device (e.g. AeroChamber Plus Flow Vu or AeroChamber Plus). Follow the instructions in the leaflet that is packed with the spacer device.
It is important that you take your dose as stated on the pharmacist’s label or as advised by your doctor. You should not take more than your prescribed dose without seeking medical advice.
If you use more Symbicort than you should, talk to your doctor or pharmacist for advice. The following effects may happen: trembling, headache or a rapid heartbeat.
Before you stop using Symbicort, you should talk to your doctor or your pharmacist. If you stop using Symbicort the signs of asthma may worsen.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Inhaled corticosteroids can affect the normal production of steroid hormones in your body, particularly if you use high doses for a long time. The effects include:
These effects are much less likely to happen with inhaled corticosteroids than with corticosteroid tablets.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Warning: The canister contains a pressurised liquid. Do not expose to temperatures higher than 50°C. Do not pierce the canister. The canister should not be broken, punctured or burnt, even when it seems empty.
The active substances are budesonide and formoterol fumarate dihydrate. Each puff contains 100 micrograms of budesonide and 3 micrograms of formoterol fumarate dihydrate.
The other ingredients are apaflurane (HFA 227), povidone and macrogol. This is a CFC-free inhaler.
Symbicort is an inhaler containing your medicine. The medicine, a white suspension for inhalation, is contained in a pressurised canister with attached dose indicator. The canister is fitted into a red plastic actuator with a white plastic mouthpiece and an integrated grey plastic dust cap. Each inhaler contains 60 or 120 puffs after it has been prepared for use. Each inhaler is individually packed in a foil wrapper containing a drying agent.
Symbicort 100 micrograms/3 micrograms/actuation pressurised inhalation, suspension (Budesonide/Formoterol fumarate dihydrate) is available in packs of one inhaler.
Not all pack sizes may be marketed.
The Marketing Authorisation for Symbicort is held by
Symbicort is manufactured by
This medicinal product is authorised in the Member States of the EEA under the following names:
Country Trade name and strength
Austria Symbicort 80 Mikrogramm/2,25 Mikrogramm/Inhalation Druckgasinhalation, Suspension
Belgium Symbicort 80 microgram/2,25 microgram/inhalatie, aërosol, suspensie; Symbicort 80 microgrammes/2,25 microgrammes/inhalation, suspension pour inhalation en flacon pressurisé; Symbicort 80 Mikrogramm/2,25 Mikrogramm/Inhalation, Druckgasinhalation, Suspension
Bulgaria Симбикорт 80 микрограма/2,25 микрограма/впръскване Суспензия под налягане за инхалация
Croatia Symbicort 80 mikrograma/2,25 mikrograma po potisku, stlačeni inhalat, suspenzija
Cyprus Symbicort 80 μικρογραμμάρια/2,25 μικρογραμμάρια/ψεκασμό
Czech Republic Symbicort 80 micrograms/2,25 micrograms/inhalation, suspension in pMDI
Denmark Symbicort 80 mikrogram/2.25 mikrogram/inhalation
Estonia Symbicort
Finland Symbicort 80 mikrog/2.25 mikrog/inhalaatio
France Symbicort 100/3 microgrammes par inhalation, suspension pour inhalation en flacon préssurisé
Greece Symbicort 80 μικρογραμμάρια/2,25 μικρογραμμάρια/ψεκασμό
Hungary Symbicort 2,25 mikrogramm/80 mikrogramm/ adag túlnyomásos inhalációs szuszpenzió
Iceland Symbicort 80 míkrógrömm/2,25 míkrógrömm/ inhalation
Italy Symbicort
Latvia Symbicort 80 mikrogrami/2.25 mikrogrami/ inhalācijā, izsmidzinājumā, aerosols inhalācijām zem spiediena
Lithuania Symbicort 80 mikrogramų/2,25 mikrogramo/išpurškime suslėgtoji įkvepiamoji suspensija
Luxembourg Symbicort 80 microgrammes/2,25 microgrammes/inhalation, suspension pour inhalation en flacon pressurisé
Malta Symbicort 100 micrograms/3 micrograms/inhalation, pressurised inhalation, suspension
Netherlands Symbicort aërosol 100/3, 100 microgram/3 microgram per dosis, aërosol, suspensie
Norway Symbicort 80 mikrogram/2.25 mikrogram/ inhalasjon
Poland Symbicort
Portugal Symbicort 80 microgramas/2,25 microgramas/inalação Suspensão pressurizada para inalação
Romania Symbicort 80 micrograme/2,25 micrograme/inhalație, suspensie de inhalat presurizată
Slovakia Symbicort 80 mikrogramov/2,25 mikrogramov/inhalačná dávka, inhalačná suspenzia v tlakovom obale
Slovenia Symbicort 80 mikrogramov/2,25 mikrograma na vdih, inhalacijska suspenzija pod tlakom
Spain Symbicort 80 microgramos/2,25 microgramos/inhalación suspensión para inhalación en envase a presión
Sweden Symbicort 80 mikrogram/2.25 mikrogram/inhalation
United Kingdom Symbicort 100 micrograms/3 micrograms/actuation pressurised inhalation, suspension
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:
0800 198 5000 (UK only)
Please be ready to give the following information:
Product name Symbicort 100/3
Reference number 17901/0349
This is a service provided by the Royal National Institute of Blind People.
This leaflet was last revised in October 2022.
© AstraZeneca 2022
SYMBICORT is a registered trademark of the AstraZeneca group of companies.
RSP 22 0100
2 Pancras Square, 8th Floor, London, N1C 4AG, UK
+44 (0)1582 838 000
www.myazmed.co.uk
+44 (0)1582 836 000
0800 783 0033
https://medicalinformation.astrazeneca.co.uk/